Process development and scale-up of recombinant protein vaccines

M11

Course Goals 

Process development and scale-up of recombinant protein vaccines.

Timeline 

Application Deadline:
June 2021

Course Dates:
11-12 October 2021 (2 days)

Organiser

Fraunhofer IME,
Aachen Germany

Participant Nr.: max. 15

Contact

Course content

A list of the course contents is given on the General strategies in process development for recombinant protein production and purification in different host systems with a special focus on state of the art methods to improve down-stream process development by implementing design of experiments and quality by design aspects, e.g. in clarification and chromatographic purification. Typical processes will be discussed using real-life equipment and examples.

Learning Outcomes

Comprehensive insight into the possibilities to conduct and improve process development and scale-up of biomanufacturing processes.

Who should apply

Scientists involved or interested in vaccine R&D and manufacturing projects.

Minimal requirements

Basic understanding of recombinant DNA technology, protein chemistry and typical process unit operations.

Accommodation

Accommodation will be provided. Travel Costs are not included.

Comments

* Due to COVID19 related delays call and training modules' schedule may be subject to change.
Be the first to know about the upcoming application calls, follow European Vaccine Initiative on Twitter and LinkedIn or subscribe to TRANSVAC Newsletter.

Weblink

Back to Training Modules

Be the first to know about the upcoming application calls, follow European Vaccine Initiative on:

  • LinkedIn Social Icon
  • Twitter Social Icon

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 730964.

Subscribe to TRANSVAC´s Mailing list

© 2021 European Vaccine Initiative. Designed by European Vaccine Initiative